“We are confident that JLABS will build upon the vibrant base in Beerse and the foundational roots of JLINX, that were established in partnership with the Bioqube Ventures team, says Stef Heylen, chief operating officer, Development, Janssen R&D and Managing Director, Janssen Pharmaceutica NV Belgium.
“We are proud to make this ecosystem part of Dr. Paul Janssen’s namesake campus,” he added.
JLABS @ BE will continue to benefit from €2.1 million of financial support granted by the European Regional Development Fund (ERDF) and the government agency Flanders Innovation & Entrepreneurship (VLAIO – Hermesfonds) in 2017.
Startups and entrepreneurs from biotech, pharmaceutical, medical device, consumer and healthtech companies interested in applying to join the JLABS @ BE community can get in touch by visiting jlabs.jnjinnovation.com
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6721833facf44b1a9067c6945b22b65c&url=https%3A%2F%2Fpharmaphorum.com%2Fnews%2Fbelgium-chosen-first-jj-jlabs-incubator-europe&c=860532953280490585&mkt=de-de
Author :
Publish date : 2024-10-26 17:00:00
Copyright for syndicated content belongs to the linked Source.
